Non-Muscle-invasive Bladder Cancer (NMIBC) Terminated Phase 1 / 2 Trials for ALT-801 (DB15386)

Back to Non-Muscle-invasive Bladder Cancer (NMIBC)

Also known as: Non-Muscle- Invasive Bladder Cancer / NMIBC / Non-muscle Invasive Bladder Cancer / Non Muscle-invasive Bladder Cancer / Non-muscle-invasive Bladder Cancer / Non-muscle Invasive Bladder Cancer (NMIBC) / Non Muscle Invasive Bladder Cancer / Nonmuscle Invasive Bladder Cancer / Non-Muscle Invasive Bladder Neoplasms / Carcinoma of urinary bladder, superficial (disorder) / Urothelial carcinoma bladder / Bladder transitional cell carcinoma / Transitional cell carcinoma of bladder (disorder)

Indication	Status	Phase
DBCOND0082324 (Non-Muscle-invasive Bladder Cancer (NMIBC))	Terminated	1 / 2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT01625260	A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer	Treatment	ALT-801 (DB15386) Gemcitabine (DB00441)